Overview
Pavel Burda practices in Prague, Czech Republic. Mr. Burda is rated as an Advanced expert by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Acute Erythroid Leukemia (AEL), Leukemia, and Rhabdomyosarcoma.
His clinical research consists of co-authoring 14 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Chronic Myelogenous Leukemia (CML).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Myelogenous Leukemia (CML)
- Experienced
- Acute Erythroid Leukemia (AEL)Mr. Burda isExperienced. Learn about Acute Erythroid Leukemia (AEL).
- Acute Myeloid Leukemia (AML)Mr. Burda isExperienced. Learn about Acute Myeloid Leukemia (AML).
- B-Cell LymphomaMr. Burda isExperienced. Learn about B-Cell Lymphoma.
- LeukemiaMr. Burda isExperienced. Learn about Leukemia.
- RhabdomyosarcomaMr. Burda isExperienced. Learn about Rhabdomyosarcoma.